Table 2

Diagnostic potential of hepcidin and implications for management in different forms of anemia

ConditionExpected hepcidin levelsIron parametersIron therapy strategiesPotential hepcidin therapy
Absolute iron deficiency anemia Low Low TSAT and ferritin By mouth, or intravenous if poorly tolerated or malabsorbed No 
Anemia of inflammation/(AI) (iron sequestration) High Low TSAT, normal to elevated ferritin Intravenous* Antagonist 
Mixed anemia (AI/IDA) Normal Low TSAT, low to normal ferritin Intravenous Antagonist 
Chronic kidney disease High Variable Intravenous Antagonist 
Resistance to ESA therapy (functional iron deficiency) High Low TSAT, variable ferritin Intravenous Antagonist 
Iron-refractory iron deficiency anemia (IRIDA) High Low TSAT and ferritin Intravenous only Antagonist 
Iron-loading anemias (eg, ineffective erythropoiesis) Low High TSAT and ferritin Iron-chelation therapy Agonist 
Iron-loading anemias treated with transfusion Normal to high High TSAT and ferritin Iron-chelation therapy Agonist 
ConditionExpected hepcidin levelsIron parametersIron therapy strategiesPotential hepcidin therapy
Absolute iron deficiency anemia Low Low TSAT and ferritin By mouth, or intravenous if poorly tolerated or malabsorbed No 
Anemia of inflammation/(AI) (iron sequestration) High Low TSAT, normal to elevated ferritin Intravenous* Antagonist 
Mixed anemia (AI/IDA) Normal Low TSAT, low to normal ferritin Intravenous Antagonist 
Chronic kidney disease High Variable Intravenous Antagonist 
Resistance to ESA therapy (functional iron deficiency) High Low TSAT, variable ferritin Intravenous Antagonist 
Iron-refractory iron deficiency anemia (IRIDA) High Low TSAT and ferritin Intravenous only Antagonist 
Iron-loading anemias (eg, ineffective erythropoiesis) Low High TSAT and ferritin Iron-chelation therapy Agonist 
Iron-loading anemias treated with transfusion Normal to high High TSAT and ferritin Iron-chelation therapy Agonist 
*

In patients receiving ESA therapy

Mixed anemia is a diagnosis of exclusion without a therapeutic trial of iron

In patients receiving ESA therapy or in patients on dialysis

Close Modal

or Create an Account

Close Modal
Close Modal